Holen Sie sich die Stockscreener-App
2.46
2.77%
-0.07
Finanzdaten der Seres Therapeutics Inc-Aktie (MCRB)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
105.59%
0.736
|
0.358 | 0.438 | 0.351 | - |
| Operating Expenses |
3.50%
22.01
|
21.27 | 19.82 | 22.83 | 24.88 |
| Operating Income/Loss |
1.75%
-21.27
|
-20.91 | -19.38 | -22.48 | -24.88 |
| Nonoperating Income/Loss |
2,501%
25.85
|
0.994 | 4.042 | 30.68 | 5.026 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
Net Income/Loss
|
123.01%
4.581
|
-19.91 | -15.34 | 8.204 | -19.86 |
| Basic Average Shares |
1.29%
9.7062
|
9.5825 | - | 8.7587 | 8.7437 |
| Diluted Average Shares |
1.72%
9.7471
|
9.5825 | - | 8.7715 | 8.7437 |
| Basic Earnings Per Share |
122.60%
0.47
|
-2.08 | - | 0.94 | -2.27 |
| Diluted Earnings Per Share |
122.60%
0.47
|
-2.08 | - | 0.94 | -2.27 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):